Get our Free Patent Expiration, Litigation, and Drug Price Updates

Serving hundreds of leading biopharmaceutical companies globally:

Medtronic
Healthtrust
Covington
Citi
Argus Health
Farmers Insurance

Generated: April 20, 2019

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 010379

« Back to Dashboard

NDA 010379 describes CYTOMEL, which is a drug marketed by King Pharms and is included in one NDA. It is available from three suppliers. Additional details are available on the CYTOMEL profile page.

The generic ingredient in CYTOMEL is liothyronine sodium. There are four drug master file entries for this compound. Nineteen suppliers are listed for this compound. Additional details are available on the liothyronine sodium profile page.
Summary for 010379
Tradename:CYTOMEL
Applicant:King Pharms
Ingredient:liothyronine sodium
Patents:0
Formulation / Manufacturing:see details
Pharmacology for NDA: 010379
Suppliers and Packaging for NDA: 010379
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
CYTOMEL liothyronine sodium TABLET;ORAL 010379 NDA A-S Medication Solutions 50090-0413 50090-0413-5 120 TABLET in 1 BOTTLE (50090-0413-5)
CYTOMEL liothyronine sodium TABLET;ORAL 010379 NDA AUTHORIZED GENERIC Greenstone LLC 59762-1206 59762-1206-1 100 TABLET in 1 BOTTLE (59762-1206-1)

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrengthEQ 0.005MG BASE
Approval Date:Approved Prior to Jan 1, 1982TE:ABRLD:Yes

Profile for product number 002

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrengthEQ 0.025MG BASE
Approval Date:Approved Prior to Jan 1, 1982TE:ABRLD:Yes

Profile for product number 003

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrengthEQ 0.05MG BASE
Approval Date:Approved Prior to Jan 1, 1982TE:ABRLD:Yes

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Chubb
Fuji
Medtronic
US Department of Justice
Teva
QuintilesIMS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.